Results 241 to 250 of about 61,506 (259)

Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial

Annals of Oncology, 2017
June-Koo Lee, M-J Ahn, Y -L Choi
exaly  

Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models

Cancer Letters, 2013
Kiyoshi Okamoto, Naoko Hata Sugi, Akihiko Tsuruoka   +2 more
exaly  

RET tyrosine kinase signaling in development and cancer

Cytokine and Growth Factor Reviews, 2005
Maria Grazia Borrello, Hannu Sariola, Elena Arighi   +2 more
exaly  

Medullary thyroid carcinoma and RET molecular testing: A virtual tumor board on clinical decision-making.

Ca-A Cancer Journal for Clinicians
Lucas Leite Cunha, Ana O Hoff, Rachel Riera   +2 more
exaly  

RET fusions in a small subset of advanced colorectal cancers at risk of being neglected

Annals of Oncology, 2018
Michele Prisciandaro, Chiara Gigliotti, Federica Di Nicolantonio   +2 more
exaly  

RET

2012
openaire   +1 more source

Real-time quantitative RT-PCR identifies distinct c-RET, RET/PTC1 and RET/PTC3 expression patterns in papillary thyroid carcinoma

Laboratory Investigation, 2004
Giovanni Tallini, Brian R Smith
exaly  

Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas

British Journal of Cancer, 2009
Valeriano Leite, Branca M. Cavaco, Margarida M Moura   +2 more
exaly  

RET is a potential tumor suppressor gene in colorectal cancer

Oncogene, 2012
Yanxin Luo
exaly  

RET

2016
openaire   +1 more source